Page 133 - DUOKOPT BIBLIOBOOK
P. 133

EFFICACY










                  Januleviciene et al





                     lar hypertension treatment study. Arch Ophthalmol 2000;   22.  Bernd AS, Pillunat LE, Bohm AG, Schmidt KG, Richard G.
                     118: 1187-94.                             Okuläre Hämodynamik und Gesichtsfeld beim Glaukom un-
                  9.   Osborne N, Melena J, Chidlow G, Wood JPM. A hypothesis   ter Dorzolamid-Therapie. Ophthalmologe 2001; 98: 451-5.
                     to explain ganglion cell death caused by vascular insults at   23.  Grunwald JE, Mathur S, Dupont J. Effects of topical dorzol-
                     the optic nerve head: possible implication for the treatment   amide on retinal and retrobulbar hemodynamics. Acta Oph-
                     of glaucoma. Br J Ophthalmol 2001; 85: 1252-9.  thalmol Scand 1997; 75: 236-8.
                  10.  Sommer A, Katz J, Quigley HA, et al. Clinically detectable   24.  Pillunat LE, Bohm AG, Koller AU, Schmidt KG, Klemm M,
                     nerve fiber atrophy precedes the onset of glaucomatous   Richard G. Effect of topical dorzolamide on optic nerve head
                     field loss. Arch Ophthalmol 1991; 109: 77-83.  blood flow. Graefes Arch Clin Exp Ophthalmol 1999; 237:
                  11.  Tuulonen A, Airaksinen P. Initial glaucomatous optic disk and   495-500.
                     retinal nerve fiber layer abnormalities and their progression.   25.  Bergstrand IC, Heijl A, Harris A. Dorzolamide and ocular
                     Am J Ophthalmol 1991; 111: 485-90.        blood flow in previously untreated glaucoma patients: a con-
                  12.  Woodward DF, Chen J. Fixed-combination and emerging   trolled double-masked study. Acta Ophthalmol Scand 2002;
                     glaucoma therapies. Exp Opin Emerg Drugs 2007; 12: 313-  80: 176-82.
                     27.                                    26.  Fuchsjäger-Mayrl G, Wally B, Georgopoulos M, et al. Ocular
                  13. Vorwerk C, Thelen U, Buchholz P, Kimmich F. Treatment of   blood flow and systemic blood pressure in patients with pri-
                     glaucoma patients with insufficient intraocular pressure con-  mary open-angle glaucoma and ocular hypertension. Invest
                     trol. Curr Med Res Opin 2008; 24: 1295-301.  Ophthalmol Vis Sci 2004; 45: 834-9.
                  14.  European Glaucoma Society. Terminology and Guidelines   27.  Choi J, Kim KH, Jeong J, Cho H, Lee CH, Kook MS. Cir-
                     for Glaucoma. III ed. Savona, Italy: Editrice DOGMA S.r.l.,   cadian fluctuation of  mean ocular  perfusion  pressure is a
                     2008; 93-111.                             consistent risk factor for normal-tension glaucoma. Invest
                  15.  Sehi M, Flanagan JG, Zeng L, Cook RJ, Trope GE. Relative   Ophthalmol Vis Sci 2007; 48: 104-11.
                     change in diurnal mean ocular perfusion pressure: a risk fac-  28.  Siesky B, Harris A, Sines D, et al. A comparative analysis of
                     tor for the diagnosis of primary open-angle glaucoma. Invest   the effects of the fixed combination of timolol and dorzo-
                     Ophthalmol Vis Sci 2005; 46: 561-7.       lamide versus latanoprost plus timolol on ocular hemody-
                  16.  Harris A, Arend O, Arend S, Martin B. Effects of topical dor-  namics and visual function in patients with primary open-
                     zolamide on retinal and retrobulbar hemodynamics. Acta   angle glaucoma. J Ocul Pharmacol Ther 2006; 22: 353-61.
                     Ophthalmol Scand 1996; 74: 569-72.     29.  Plange N, Kaup M, Arend O, Remky A. Asymmetric visual
                  17.  Harris A, Arend O, Kagemann L, Garrett M, Chung HS, Martin   field loss and retrobulbar haemodynamics in primary open-
                     B. Dorzolamide, visual function and ocular hemodynamics in   angle glaucoma. Graefes Arch Clin Exp Ophthalmol 2006;
                     normal-tension glaucoma. J Ocul Pharmacol Ther 1999; 15:   244: 978-83.
                     189-97.                                30.  Zeitz O, Galambos P, Wagenfeld L, et al. Glaucoma progres-
                  18.  Harris A, Arend O, Chung HS, Kageman L, Cantor L, Martin   sion is associated with decreased blood flow velocities in
                     B. A comparative study of betaxolol and dorzolamide effect   the short posterior ciliary artery. Br J Ophthalmol 2006; 90:
                     on ocular circulation in normal-tension glaucoma patients.   1245-8.
                     Ophthalmology 2000; 107: 430-4.        31.   Galassi F, Sodi A, Ucci F, Renieri G, Pieri B, Baccini M. Ocu-
                  19.  Harris A, Jonescu-Cuypers CP, Kagemann L, et al. Effect   lar hemodynamics and glaucoma prognosis: a color Doppler
                     of dorzolamide timolol combination versus timolol 0.5% on   imaging study. Arch Ophthalmol 2003; 121: 1711-5.
                     ocular blood flow in patients with primary open-angle glau-  32.  Plange N, Kaup M, Weber A, Arend KO, Remky A. Retrobulbar
                     coma. Am J Ophthalmol 2001; 132: 490-5.   haemodynamics and morphometric optic disc analysis in primary
                  20.  Martinez A, Gonzalez F, Capeans C, Perez R, Sanchez-Salo-  open-angle glaucoma. Br J Ophthalmol 2006; 90: 1501-4.
                     rio M. Dorzolamide effect on ocular blood flow. Invest Oph-  33.  Reus NJ, Lemij HG. Diagnostic accuracy of the GDxVCC for
                     thalmol Vis Sci 1999; 40: 1270-5.         glaucoma. Ophthalmology 2004; 111: 1860-5.
                  21.  Avunduk AM, Sari A, Akyol N, et al. The one-month effects   34.  Medeiros FA, Vizzeri G, Zangwill LM, Alencar LM, Sample
                     of topical betaxolol, dorzolamide and apraclonidine on ocu-  PA, Weinreb RN. Comparison of retinal nerve fiber layer and
                     lar blood flow velocities in patients with newly diagnosed   optic disc imaging for diagnosing glaucoma in patients sus-
                     primary open-angle glaucoma. Ophthalmologica 2001; 215:   pected of having the disease. Ophthalmology 2008; 115:
                     361-5.                                    1340-6.








                                                                                                797


             EJO_790-797_Janule.indd   797                                                      3-08-2009   14:04:15






                                                                                                                   133
   128   129   130   131   132   133   134   135   136   137   138